Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0006 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0007 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |